PAUL BERNS

Profile

First Name

: PAUL

Middle Name

:

Last Name

: BERNS

Related Companies
Titles
Company Name
Related People
DIRECTOR
ANACOR PHARMACEUTICALS, INC.
SANJAY CHANDA, IRWIN HEYMAN, ZHI HONG, ANDERS HOVE, PAUL KLINGENSTEIN, MARK LESCHLY, KIRK MAPLES, RICHARD MARKHAM, GEOFFREY PARKER, DAVID PERRY, JACOB PLATTNER, WILLIAM RIEFLIN, LUCY SHAPIRO, LEE ZANE
DIRECTOR
CELLECTAR BIOSCIENCES, INC.
CHARLES T. BERNHARDT, JAMES V. CARUSO, ASHER ALBAN CHANAN-KAHN, MICHAEL J. DOYLE, FREDERICK W DRISCOLL, FREDERICK W. DRISCOLL, DOV ELEFANT, SIMM FASS, JOHN FRIEND, JOHN E. FRIEND II, JOHN P. HAMILL, KIM HAWKINS, STEPHEN A. HILL, CHAD J. KOLEAN, DARRELL SHANE LEA, JARROD LONGCOR, STEFAN LOREN, STEFAN D. LOREN, THOMAS ROCKWELL MACKIE, JAMES S. MANUSO, DAVID B. MCWILLIAMS, JOHN E. NEIDERHUBER, JOHN NEIS, ELIAS NYBERG, HARRY S. PALMIN, CHRISTOPHER J. PAZOLES, SIMON PEDDER, JOANNE M. PROTANO, HOWARD M. SCHNEIDER, KRISTIN C. SCHUHWERK, ANDREI SHUSTOV, DOUGLAS J. SWIRSKY, MICHAEL F. TWEEDLE, JAMEY P. WEICHERT
DIRECTOR
UNITY BIOTECHNOLOGY, INC.
KRISTINA BUROW, GRAHAM COOPER, JAMIE DANANBERG, NATHANIEL DAVID, NATHANIEL E. DAVID, TROY FOSTER, BOB GOELTZ, KEITH KLEIN, KEITH LEONARD, DAN MARQUESS, ROBERT NELSEN, CAMILLE SAMUELS, JOHN SMITHER, TAMARA TOMPKINS
EXECUTIVE OFFICER
ARCH VENTURE FUND XII, L.P.
N/A ARCH VENTURE PARTNERS XII, L.P., N/A ARCH VENTURE PARTNERS XII, LLC, KRISTINA BUROW, KEITH L. CRANDELL, JASON DOREN, STEVEN GILLIS, MARK MCDONNELL, ROBERT T. NELSEN
DIRECTOR
ELEPHAS BIOSCIENCES CORP
MANEESH K. ARORA, MICHELLE B. ARORA, TERRENCE BRADY, TERRENCE P. BRADY, STEVEN GALSON, ANDREA JACKSON, JONATHAN OLINER
DIRECTOR
ARETEIA THERAPEUTICS, INC.
JORGE BARTOLOME, DANIEL BECKER, WHIT BERNARD, MICHAEL E. BOZIK, STEPHEN BUTTS, CHRISTOPHER COURTS, CHRISTOPHER TODD COX, BENJAMIN GOMEZ, ADAM KOPPEL, IAN READ, ELYSE STOCK, CHRIS VISIOLI, ROBIN WALKER
EXECUTIVE OFFICER, DIRECTOR
NEUMORA THERAPEUTICS, INC.
KRISTINA BUROW, MATTHEW FUST, ALAA HALAWA, MAYKIN HO, ROBERT NELSEN, JOSHUA PINTO, KARI STEFANSSON, TAMARA TOMPKINS, STACIE WENINGER
DIRECTOR
MIRADOR THERAPEUTICS, INC.
TIMOTHY K. ANDREWS, DAVID BONITA, M.D., VIKA BROUGH, KRISTINA BUROW, SCOTT GLENN, MARK C. MCKENNA, JOSEPH PAPA
DIRECTOR
OLLIN BIOSCIENCES, INC.
CARIAD CHESTER, FRED COHEN, JASON COLOMA, JASON EHRLICH, ALAA HALAWA, TRAVIS MURDOCH
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-06-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2026-05-14 
2025-02-21
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-06-15 
2024-04-03
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2024-02-15 
2024-04-03
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2023-12-14 
2024-02-22
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-06-15 
2024-01-09
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2023-11-30 
2023-01-03
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2020-09-08 
2022-09-14
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2022-08-15 
2022-07-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-06-15 
2022-04-01
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2022-02-04 
2018-03-27
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-03-15 
2014-08-15
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Debt 
2014-08-01 
2013-06-17
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2013-06-07 
2013-04-09
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2013-04-05